Navigation Links
Martek Announces First Quarter 2009 Financial Results
Date:3/4/2009

- Product sales of $84.0 million, a 7% increase over last year's first

quarter

- Total revenue of $87.4 million, up 5% year-over-year

- Record pre-tax income of $15.4 million

- Earnings per share of $0.29, an increase of 12% over last year's

first quarter

- New products launched containing life'sDHA(TM) in a variety of

categories

- Improvements in gross margin continue to demonstrate the strong

leverage in our business

COLUMBIA, Md., March 4 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) today announced its financial results for the first quarter of fiscal 2009. Revenues for the first quarter were $87.4 million, up 5% from $82.9 million in the first quarter of fiscal 2008. Net income was $9.6 million, or $0.29 per diluted share, for the first quarter of fiscal 2009 compared with $8.7 million, or $0.26 per diluted share, in last year's first quarter.

Commenting on the quarter, Chief Executive Officer Steve Dubin said, "Despite the troubling economy, Martek's first quarter results showed both revenue and bottom line growth reflecting the strength of our core infant formula business, growing consumer awareness of the health benefits of DHA beyond infant formula markets and the continued execution of our business plan. Net profits increased faster than revenue due to additional gross margin growth resulting from manufacturing improvements and increased plant utilization. While the current economy continues to present challenges for Martek as well as other businesses, I believe Martek continues to be well-positioned to deliver both revenue and profit growth in 2009."

Revenue Summary

Product sales in the first quarter of fiscal 2009 increased 7% year-over-year to $84.0 million,
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Martek, General Mills Collaborate on Microencapsulation Technology for Food Applications
2. Martek to Present at 11th Annual ICR XChange
3. Martek to Present at Upcoming Needham Conference
4. Martek Announces Fourth Quarter and FY 2008 Financial Results
5. Martek to Announce Fourth Quarter and Fiscal Year 2008 Results
6. Frost & Sullivan Recognizes Martek Biosciences for Unique and Customer-Focused Strategies With Customer Value Enhancement Award
7. Martek to Present at Upcoming Canaccord Adams Conference
8. Martek to be the Sole Source Supplier of DHA and ARA for Infant Formulas Produced By Grupo Ricap
9. Martek is Now the Sole-Source Supplier of ARA for all Infant Formula Products Manufactured by Hochdorf Nutricare
10. Martek Signs Multi-Year Sole-Source Supply Agreement With Hero
11. Martek Announces Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... 2, 2015 MGB Biopharma ... resistance problem  MGB Biopharma, a biopharmaceutical ... to address the major global problem of antibiotic ... stable intravenous (IV) formulation of MGB-BP-3, designed for the ... The intravenous formulation of MGB-BP-3 is ...
(Date:6/1/2015)... New York, NY (PRWEB) June 02, 2015 ... informative views on health care, Jack Uldrich has ... pharmaceutical firm in New York today. He will ... , Uldrich has delivered presentations to ... American Academies of Audiology and Neurology, Alcetel-Lucent/Verizon Forum ...
(Date:6/1/2015)... South Korea , June 1, 2015 /PRNewswire/ ... Biotherapeutics Inc. (GCBT) kicked off construction today on its ... Technoparc,s Saint-Laurent Campus. The CA$315 million project represents one ... Canada in the biopharmaceutical industry, giving ... (IVIG) and albumin manufacturing plant in Canada ...
(Date:6/1/2015)... -- About Bio-alcohols Bio-alcohols are organic ... Bio-alcohols are primarily used in the transportation sector. For ... gasoline in cars. Technavio,s analysts forecast the global bio-alcohols ... over the period 2014-2019. Covered in ... into five: transportation, infrastructure, medical, and others. Technavio,s report, ...
Breaking Biology Technology:MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 2MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 3Futurist Jack Uldrich to Address the Future of Pharmaceuticals 2Green Cross Biotherapeutics Kicks Off Construction in Montreal 2Green Cross Biotherapeutics Kicks Off Construction in Montreal 3Global Bio-alcohols Market 2015-2019 2
... Sept. 10 Abeome Corporation, a,Georgia-based biotech company, ... (SAB) to collaborate on the development of,Abeome,s ovarian ... therapeutic,and diagnostic projects for the company., The ... Meagher, PhD, Chief,Scientific Officer for Abeome, Distinguished Research ...
... Generation of Drug Candidates ... for Inflammatory Diseases, ... Cellzome Inc. and GlaxoSmithKline (LSE & NYSE:,GSK) announce the ... novel kinase-targeted therapeutics to treat inflammatory,diseases., The alliance gives ...
... Sept. 9 /PRNewswire-FirstCall/ - ARIUS Research Inc., (TSX:,ARI), ... wave of,antibody therapeutics, today announced that RiskMetrics ISS ... they have no,objection to the transaction, and are ... the proposed plan of arrangement whereby Roche,will acquire ...
Cached Biology Technology:Abeome Forms First Class Scientific Advisory Board 2GlaxoSmithKline and Cellzome Announce Major Strategic Alliance 2GlaxoSmithKline and Cellzome Announce Major Strategic Alliance 3GlaxoSmithKline and Cellzome Announce Major Strategic Alliance 4Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche 2Arius announces leading independent proxy firm, RiskMetrics ISS Canada, recommends shareholders vote for the arrangement involving its acquisition by Roche 3
(Date:5/20/2015)... OXFORD, Conn. , May 20, 2015 ... "Company") announces that its wholly owned subsidiary, 3D-ID LLC, ... contractor under Team Battelle for the biometrics technology portion ... Unrestricted Suite Contract from the Department of the Army. ... facial recognition products developed for government, law enforcement and ...
(Date:5/19/2015)... 19, 2015  Technology is rapidly advancing, outpacing enterprises, ... the cloud. Passwords and their management are soon to ... standards-based specifications such as those developed by the FIDO ... passwords presents for BYOD, COPE, IoT, and mobile payments, ... protocol. In response to the call ...
(Date:5/18/2015)... , May 18, 2015 Fingerprint ... sensors FPC1020, FPC1025, FPC1145, FPC1155 and FPC1035 from one if ... June until and including Q3 2015 and the sensors will ... . Communicated order values for 2015 hereby amount to 740 ... Q1 2015 of 140 MSEK and a number of smaller ...
Breaking Biology News(10 mins):NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 2NXT-ID, Inc Announces Participation as Member of Team Battelle for TIES Contract Award 3HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 2HYPR Corp. Biometric Security Integration Kit Shields Applications and Devices Across the Internet of Things 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
... Manipulation of cells by a new microfluidic device may ... the body,s own immune cells to fight such diseases ... neuroblastoma. The therapy, known as adoptive T cell ... treatment involves removing disease-fighting immune cells called T cells ...
... engineered bacteria to churn out a gasoline-like biofuel at ... breakthrough that could soon provide an affordable and "green" ... week in advance of publication in the journal ... assistant professor of chemistry at UC Berkeley, graduate student ...
... NJ The American Heart Association estimates 35 percent of ... of risk factors characterized by obesity and the simultaneous presence ... sugar and lipids. In patients with metabolic syndrome, high ... in turn affects the organ,s ability to filter waste from ...
Cached Biology News:Researchers predict age of T cells to improve cancer treatment 2Researchers predict age of T cells to improve cancer treatment 3Turning bacteria into butanol biofuel factories 2Turning bacteria into butanol biofuel factories 3Study shows pine bark naturally improves kidney function in patients with metabolic syndrome 2Study shows pine bark naturally improves kidney function in patients with metabolic syndrome 3
Buffer used for mitocapture assays....
... CyScribe GFX Purification Kit, 25 ... CyDye labeled cDNA probesProvides efficient removal ... from labeling reactions with superior yields ... for the purification of cDNA labeled ...
Propidium Iodide: {3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diodide}. Antifade Solution: p-Phenylenediamine and glycerol in PBS solution. 2.5ug/mL Propidium Iodide (PI)...
Detects activated caspases in living cells. Simple/sensitive/straight-forward procedure takes only 30 minutes. Results can be analyzed by flow cytometry/fluorescence microscopy/fluorescence plate rea...
Biology Products: